133 related articles for article (PubMed ID: 38428665)
1. Uncovering the toxicity mechanisms of a series of carboxylic acids in liver cells through computational and experimental approaches.
Ortega-Vallbona R; Méndez R; Tolosa L; Escher SE; Castell JV; Gozalbes R; Serrano-Candelas E
Toxicology; 2024 May; 504():153764. PubMed ID: 38428665
[TBL] [Abstract][Full Text] [Related]
2. B-13 progenitor-derived hepatocytes (B-13/H cells) model lipid dysregulation in response to drugs and chemicals.
Leitch AC; Probert PME; Shayman JA; Meyer SK; Kass GEN; Wright MC
Toxicology; 2017 Jul; 386():120-132. PubMed ID: 28552552
[TBL] [Abstract][Full Text] [Related]
3. Human Upcyte Hepatocytes: Characterization of the Hepatic Phenotype and Evaluation for Acute and Long-Term Hepatotoxicity Routine Testing.
Tolosa L; Gómez-Lechón MJ; López S; Guzmán C; Castell JV; Donato MT; Jover R
Toxicol Sci; 2016 Jul; 152(1):214-29. PubMed ID: 27208088
[TBL] [Abstract][Full Text] [Related]
4. Benzbromarone aggravates hepatic steatosis in obese individuals.
Sun P; Zhu JJ; Wang T; Huang Q; Zhou YR; Yu BW; Jiang HL; Wang HY
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2067-2077. PubMed ID: 29526820
[TBL] [Abstract][Full Text] [Related]
5. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model.
Weber LW; Boll M; Stampfl A
Crit Rev Toxicol; 2003; 33(2):105-36. PubMed ID: 12708612
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of hepatic fatty acid transporters and inhibition/down-regulation of hepatic OCTN2 contribute to olanzapine-induced liver steatosis.
Jiang T; Zhang Y; Bai M; Li P; Wang W; Chen M; Ma Z; Zeng S; Zhou H; Jiang H
Toxicol Lett; 2019 Nov; 316():183-193. PubMed ID: 31437515
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of hepatotoxic drugs in human hepatocytes from multiple donors: Identification of P450 activity as a potential risk factor for drug-induced liver injuries.
Utkarsh D; Loretz C; Li AP
Chem Biol Interact; 2016 Aug; 255():12-22. PubMed ID: 26718876
[TBL] [Abstract][Full Text] [Related]
8. Implication of hepatic transporters (MDR1 and MRP2) in inflammation-associated idiosyncratic drug-induced hepatotoxicity investigated by microvolume cytometry.
Saab L; Peluso J; Muller CD; Ubeaud-Sequier G
Cytometry A; 2013 Apr; 83(4):403-8. PubMed ID: 23401306
[TBL] [Abstract][Full Text] [Related]
9. Conserved valproic-acid-induced lipid droplet formation in Dictyostelium and human hepatocytes identifies structurally active compounds.
Elphick LM; Pawolleck N; Guschina IA; Chaieb L; Eikel D; Nau H; Harwood JL; Plant NJ; Williams RS
Dis Model Mech; 2012 Mar; 5(2):231-40. PubMed ID: 22003123
[TBL] [Abstract][Full Text] [Related]
10. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase.
Kim YJ; Hwang SH; Jia Y; Seo WD; Lee SJ
Food Res Int; 2017 Nov; 101():209-217. PubMed ID: 28941686
[TBL] [Abstract][Full Text] [Related]
11. A lipidomic cell-based assay for studying drug-induced phospholipidosis and steatosis.
García-Cañaveras JC; Peris-Díaz MD; Alcoriza-Balaguer MI; Cerdán-Calero M; Donato MT; Lahoz A
Electrophoresis; 2017 Sep; 38(18):2331-2340. PubMed ID: 28512733
[TBL] [Abstract][Full Text] [Related]
12. The use of hepatocytes to investigate drug toxicity.
Gómez-Lechón MJ; Castell JV; Donato MT
Methods Mol Biol; 2010; 640():389-415. PubMed ID: 20645064
[TBL] [Abstract][Full Text] [Related]
13. High fat diet feeding exaggerates perfluorooctanoic acid-induced liver injury in mice via modulating multiple metabolic pathways.
Tan X; Xie G; Sun X; Li Q; Zhong W; Qiao P; Sun X; Jia W; Zhou Z
PLoS One; 2013; 8(4):e61409. PubMed ID: 23626681
[TBL] [Abstract][Full Text] [Related]
14. Sortilin 1 Modulates Hepatic Cholesterol Lipotoxicity in Mice via Functional Interaction with Liver Carboxylesterase 1.
Li J; Wang Y; Matye DJ; Chavan H; Krishnamurthy P; Li F; Li T
J Biol Chem; 2017 Jan; 292(1):146-160. PubMed ID: 27881673
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial protein adducts formation and mitochondrial dysfunction during N-acetyl-m-aminophenol (AMAP)-induced hepatotoxicity in primary human hepatocytes.
Xie Y; McGill MR; Du K; Dorko K; Kumer SC; Schmitt TM; Ding WX; Jaeschke H
Toxicol Appl Pharmacol; 2015 Dec; 289(2):213-22. PubMed ID: 26431796
[TBL] [Abstract][Full Text] [Related]
16. Overview of hepatotoxicity.
Meyer SA
Curr Protoc Toxicol; 2001 Aug; Chapter 14():Unit 14.1. PubMed ID: 23045037
[TBL] [Abstract][Full Text] [Related]
17. Metabolomic effects of CeO
Kitchin KT; Stirdivant S; Robinette BL; Castellon BT; Liang X
Part Fibre Toxicol; 2017 Nov; 14(1):50. PubMed ID: 29187207
[TBL] [Abstract][Full Text] [Related]
18. Pluripotent Stem Cell-Derived Hepatocytes Phenotypic Screening Reveals Small Molecules Targeting the CDK2/4-C/EBPα/DGAT2 Pathway Preventing ER-Stress Induced Lipid Accumulation.
Parafati M; Bae SH; Kirby RJ; Fitzek M; Iyer P; Engkvist O; Smith DM; Malany S
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33334026
[TBL] [Abstract][Full Text] [Related]
19. [Hepatotoxicity of antineoplastic agents].
Karpova GV; Fomina TI; Vetoshkina TV; Dubskaia TIu; Ermolaeva LA; Churin AA
Vestn Ross Akad Med Nauk; 2009; (11):17-20. PubMed ID: 20017402
[TBL] [Abstract][Full Text] [Related]
20. Metabolomics-based strategy to assess drug hepatotoxicity and uncover the mechanisms of hepatotoxicity involved.
Martínez-Sena T; Moro E; Moreno-Torres M; Quintás G; Hengstler J; Castell JV
Arch Toxicol; 2023 Jun; 97(6):1723-1738. PubMed ID: 37022445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
